Since the abnormal clumping of proteins in motor neurons is a hallmark of ALS, it is in the focus in ALS treatment. Researchers are exploring various strategies to prevent protein misfolding or clear these aggregates, potentially slowing neurodegeneration. This includes drugs targeting specific proteins and potential gene therapies aimed at reducing mutant protein production.